Biotech Stocks for Options Bears to Focus on Today
Crispr Therapeutics (NASDAQ: CRSP): A Seven-Day Streak Faces Headwinds Crispr Therapeutics Inc. (NASDAQ: CRSP) has experienced a notable rally this June, but the momentum appears to be waning. With shares currently down 0.6% to $42.69, … Read more